Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-11-10

Clinical Trial Update: Dexmedetomidine on Optic Nerve Sheath Diameter [NA]

View source ↗

Summary

A clinical trial evaluating dexmedetomidine on optic nerve sheath diameter for intracranial hypertension has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Gachon University Gil Medical Center | Conditions: Intracranial Hypertension | NA | Status: WITHDRAWN